N/A
N=133
Chronic Obstructive Pulmonary Disease Markers and Prognosis
Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT00605540 ↗Enrolled (actual)
133
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcome: Primary: Forced Expiratory Volume in the First Second (FEV1) — 54; 54 Percentage predicted — p=0.09
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- UPECLIN HC FM Botucatu Unesp
- Primary completion
- Mar 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Forced Expiratory Volume in the First Second (FEV1) |
54; 54 | 0.09 |
| PRIMARY Exercise Tolerance |
438; 412 | — |
| PRIMARY Body Composition |
25; 25 | — |
| PRIMARY Dyspnea |
1; 2 | — |
| PRIMARY Health Status |
42; 44 | — |
Summary
The study aim is to verify the association between the changes in markers of disease and patient´s prognosis in chronic obstructive pulmonary disease.
Eligibility Criteria
Inclusion Criteria
- COPD diagnosis according to the GOLD criteria
Exclusion Criteria
- Asthma
- Inability to perform pulmonary function and exercise tolerance tests
- Recent myocardial infarction or unstable angina
- Congestive heart failure: class III/IV
Data sourced from ClinicalTrials.gov (NCT00605540). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.